ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

November 27, 1998

In Brief: ACS Awards Professorship To Bernstein; HCFA Clears Dana-Farber For Medicare

August 11, 1995

ONS Urges Congress To Back Anti-Tobacco Measures.

July 20, 2001

NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs

June 15, 2012

Study Finds More Deaths On Aranesp Arm In Cancer Anemia Study, No Benefit Seen.

February 2, 2007

Includes April issue of Business & Regulatory Report (8 pages).

May 2, 2003